Total Payments
$13,827
2023 Payments
$150.43
Companies
15
Transactions
34
Payment Breakdown by Category
Consulting$10,835 (78.4%)
Travel$1,936 (14.0%)
Food & Beverage$1,027 (7.4%)
Education$29.20 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,835 | 5 | 78.4% |
| Travel and Lodging | $1,936 | 7 | 14.0% |
| Food and Beverage | $1,027 | 20 | 7.4% |
| Education | $29.20 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $5,320 | 10 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $5,097 | 5 | $0 (2019) |
| PFIZER INC. | $2,400 | 1 | $0 (2018) |
| Incyte Corporation | $428.26 | 2 | $0 (2018) |
| Medtronic, Inc. | $150.43 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $149.96 | 3 | $0 (2018) |
| Amgen Inc. | $125.34 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $33.95 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $30.21 | 2 | $0 (2018) |
| Pharmacyclics LLC, An AbbVie Company | $17.16 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $150.43 | 1 | Medtronic, Inc. ($150.43) |
| 2020 | $12.45 | 1 | Karyopharm Therapeutics Inc. ($12.45) |
| 2019 | $5,114 | 6 | JAZZ PHARMACEUTICALS INC. ($5,097) |
| 2018 | $8,170 | 18 | Daiichi Sankyo Inc. ($5,320) |
| 2017 | $379.80 | 8 | Merck Sharp & Dohme Corporation ($131.21) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/25/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $150.43 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/22/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Education | In-kind items and services | $12.45 | General |
| Category: Oncology | ||||||
| 08/08/2019 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Education | In-kind items and services | $16.75 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2019 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| 03/13/2019 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $4,050.00 | General |
| 03/02/2019 | JAZZ PHARMACEUTICALS INC. | — | Travel and Lodging | Cash or cash equivalent | $259.16 | General |
| 03/02/2019 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | Cash or cash equivalent | $188.52 | General |
| 03/02/2019 | JAZZ PHARMACEUTICALS INC. | — | Travel and Lodging | Cash or cash equivalent | $149.64 | General |
| 12/11/2018 | PFIZER INC. | MYLOTARG (Biological) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2018 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 10/22/2018 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $477.42 | General |
| 10/19/2018 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $57.36 | General |
| 10/19/2018 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $23.33 | General |
| 10/18/2018 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $68.10 | General |
| 10/17/2018 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $154.44 | General |
| 10/17/2018 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $48.59 | General |
| 10/17/2018 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $19.36 | General |
| 10/17/2018 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $10.00 | General |
| 10/03/2018 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $861.60 | General |
| 05/09/2018 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $335.00 | General |
| 03/27/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Oncology | ||||||
| 03/09/2018 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Hematology | ||||||
| 02/21/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $33.95 | General |
| 02/16/2018 | Amgen Inc. | Blincyto (Biological), IMLYGIC | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 02/12/2018 | Helsinn Therapeutics (U.S.), Inc. | ALOXI (Drug), ZYKADIA, AKYNZEO | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: ONCOLOGY | ||||||
About Dr. Andrew Yeager, MD
Dr. Andrew Yeager, MD is a Hematology & Oncology healthcare provider based in The Plains, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750440996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Yeager, MD has received a total of $13,827 in payments from pharmaceutical and medical device companies, with $150.43 received in 2023. These payments were reported across 34 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($10,835).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location The Plains, VA
- Active Since 12/06/2006
- Last Updated 07/14/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1750440996
Products in Payments
- MYLOTARG (Biological) $2,400
- INTELLIS ADAPTIVESTIM (Device) $150.43
- NOXAFIL (Drug) $143.75
- Blincyto (Biological) $109.69
- JAKAFI (Drug) $93.26
- DARZALEX (Biological) $30.21
- Imbruvica (Drug) $17.16
- ALOXI (Drug) $16.81
- ELZONRIS (Drug) $16.75
- Nplate (Biological) $15.65
- Beleodaq (Drug) $15.55
- XPOVIO (Drug) $12.45
- XTANDI (Drug) $12.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.